We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction

This study is currently recruiting participants.
Verified August 2017 by UNC Lineberger Comprehensive Cancer Center
Sponsor:
ClinicalTrials.gov Identifier:
NCT01578954
First Posted: April 17, 2012
Last Update Posted: August 22, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Celgene
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2023
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)